Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study

被引：2

作者：

Autore, Francesco ^{[1
]}

Visentin, Andrea ^{[2
]}

Deodato, Marina ^{[3
]}

Vitale, Candida ^{[4
,5
]}

Galli, Eugenio ^{[1
]}

Fresa, Alberto ^{[1
]}

Fazzi, Rita ^{[6
]}

Sanna, Alessandro ^{[7
]}

Olivieri, Jacopo ^{[8
]}

Scortechini, Ilaria ^{[9
]}

Del Principe, Maria Ilaria ^{[10
]}

Sportoletti, Paolo ^{[11
]}

Schiattone, Luana ^{[12
]}

Maschio, Nilla ^{[13
]}

Facchinelli, Davide ^{[14
]}

Marchesi, Francesco ^{[15
]}

Coscia, Marta ^{[4
,5
]}

Tedeschi, Alessandra ^{[3
]}

Trentin, Livio ^{[2
]}

Innocenti, Idanna ^{[1
]}

Candoni, Anna ^{[8
,16
]}

Busca, Alessandro ^{[4
,5
]}

Pagano, Livio ^{[1
]}

Laurenti, Luca ^{[1
]}

机构：

[1] Fdn Policlin Univ A Gemelli IRCCS, Largo Agostino Gemelli 8, I-00168 Rome, Italy

[2] Univ Padua, Padua, Italy

[3] ASST Grande Osped Metropolitano Niguarda, Milan, Italy

[4] Univ Torino, AOU Citta Salute & Sci Torino, Turin, Italy

[5] Univ Torino, Dipartimento Biotecnol Mol & Sci Salute, Turin, Italy

[6] Azienda Osped Univ Pisana, Pisa, Italy

[7] Azienda Osped Univ Careggi, Florence, Italy

[8] Clin Ematol Udine, Udine, Italy

[9] Azienda Osped Univ Marche, Ancona, Italy

[10] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Rome, Italy

[11] AO Santa Maria Misericordia Perugia, Perugia, Italy

[12] Presidio Osped S Spirito Pescara, Pescara, Italy

[13] Oncoematol Ist Oncol Veneto IOV IRCCS, Padua, Italy

[14] Osped San Bortolo, Vicenza, Italy

[15] IRCCS Regina Elena Natl Canc Inst, Rome, Italy

[16] Univ Modena & Reggio Emilia, Modena, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 05期

关键词：

RITUXIMAB;

D O I：

10.1002/ajh.27247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：982 / 984

页数：3

共 50 条

[31] Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)
Hampel, Paul J.
Rabe, Kari G.
Wang, Yucai
Kenderian, Saad S.
Ding, Wei
Muchtar, Eli
Leis, Jose F.
Koehler, Amber
Tsang, Mazie
Parrondo, Ricardo
Bubik, Rachel
Schwager, Susan Marie
Hanson, Curtis A.
Braggio, Esteban
Slager, Susan L.
Shi, Min
Van Dyke, Daniel L.
Call, Timothy G.
Kay, Neil E.
Parikh, Sameer A.
BLOOD, 2023, 142
[32] Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study
Tremblay, Douglas
Csizmar, Clifford
DiNardo, Courtney D.
Ball, Somedeb
Rippel, Noa
Hammond, Danielle
Kadia, Tapan M.
Ravandi, Farhad
Chien, Kelly
Van Hyfte, Grace
Mazumdar, Madhu
Saliba, Antoine
Mangaonkar, Abhishek
Lasho, Terra
Al-Kali, Aref
Kremyanskaya, Marina
Feld, Jonathan
Silverman, Lewis R.
Komrokji, Rami
Mascarenhas, John
Padron, Eric
Garcia-Manero, Guillermo
Sallman, David A.
Patnaik, Mrinal M.
Montalban-Bravo, Guillermo
LEUKEMIA, 2025, 39 (01) : 257 - 260
[33] Real-World Efficacy of Venetoclax-Based Regimens in Patients with Chronic Lymphocytic Leukemia in Israel: A Multicenter Prospective Study
Herishanu, Yair
Goldschmidt, Neta
Itchaki, Gilad
Levi, Itai
Aviv, Ariel
Fineman, Riva
Dally, Najib
Tadmor, Tamar
Ruchlemer, Rosa
Abadi, Uri
Shvidel, Lev
Braester, Andrei
Cohen, Raanan
Frankel, Neta
Ofek, Keren
Berelovich, Jenia
Grunspan, Moshe
Benjamini, Ohad
BLOOD, 2021, 138 : 3727 - +
[34] TREATMENT OF INFECTIOUS AND HIGH-RISK PATIENTS
COWLING, RD
BRITISH DENTAL JOURNAL, 1988, 164 (08) : 238 - 238
[35] Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia
Fischer, Kirsten
Al-Sawaf, Othman
Hallek, Michael
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 357 - 362
[36] Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study
Zugasti, Ines
Castano-Diez, Sandra
Esteban, Daniel
Avendano Pita, Alejandro
Pomares, Helena
Perez Gonzalez, Ana
Garcia-Avila, Sara
Padilla-Conejo, Irene
de la Fuente, Cristina
Martinez-Roca, Alexandra
Guijarro, Francesca
Alamo Moreno, Jose Ramon
Jimenez-Vicente, Carlos
Cortes-Bullich, Albert
Torrecillas, Victor
Guardia, Ares
Munarriz, Daniel
Carcelero, Esther
Suarez-Lledo, Maria
Queralt Salas, Maria
Lopez, Felix
Ramos, Fernando
Xicoy, Blanca
Valcarcel, David
Arnan Sangerman, Montserrat
Diez-Campelo, Maria
Martinez, Carmen
Rovira, Montserrat
Fernandez-Aviles, Francesc
Esteve, Jordi
Diaz-Beya, Marina
BLOOD, 2023, 142
[37] Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
Del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
BLOOD, 2023, 142
[38] Incidence and risk of tumor lysis syndrome in patients with chronic lymphocytic leukemia (CLL) treated with venetoclax outside the context of a clinical trial
Koehler, Amber
Leung, Nelson
Finnes, Heidi
Call, Timothy
Rabe, Kari
Achenbach, Sara
Ding, Wei
Kenderian, Saad
Leis, Jose
Muchtar, Eli
Hayman, Suzanne
Fonder, Amie
Schwager, Susan
Slager, Susan
Kay, Neil
Parikh, Sameer
LEUKEMIA & LYMPHOMA, 2020, 61 : 231 - 233
[39] Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice
Koehler, Amber B.
Leung, Nelson
Call, Timothy G.
Rabe, Kari G.
Achenbach, Sara J.
Ding, Wei
Kenderian, Saad S.
Leis, Jose F.
Wang, Yucai
Muchtar, Eli
Hayman, Suzanne R.
Hampel, Paul J.
Finnes, Heidi D.
Schwager, Susan M.
Slager, Susan L.
Kay, Neil E.
Parikh, Sameer A.
LEUKEMIA & LYMPHOMA, 2020, 61 (10) : 2383 - 2388
[40] Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia
Irving, Laura
Mainou-Fowler, Tryfonia
Parker, Anton
Ibbotson, Rachel E.
Oscier, David G.
Strathdee, Gordon
EPIGENETICS, 2011, 6 (03) : 300 - 306

← 1 2 3 4 5 →